KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Other financing activities (2016 - 2025)

Historic Other financing activities for Fulgent Genetics (FLGT) over the last 8 years, with Q3 2025 value amounting to $357000.0.

  • Fulgent Genetics' Other financing activities fell 1716.94% to $357000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 2492.71%. This contributed to the annual value of $2.9 million for FY2024, which is 611.27% up from last year.
  • Latest data reveals that Fulgent Genetics reported Other financing activities of $357000.0 as of Q3 2025, which was down 1716.94% from $345000.0 recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Other financing activities registered a high of $4.1 million during Q4 2021, and its lowest value of $39000.0 during Q2 2021.
  • Over the past 5 years, Fulgent Genetics' median Other financing activities value was $513000.0 (recorded in 2021), while the average stood at $926315.8.
  • The largest annual percentage gain for Fulgent Genetics' Other financing activities in the last 5 years was 101794.87% (2022), contrasted with its biggest fall of 9237.64% (2022).
  • Fulgent Genetics' Other financing activities (Quarter) stood at $4.1 million in 2021, then crashed by 92.38% to $316000.0 in 2022, then skyrocketed by 252.53% to $1.1 million in 2023, then tumbled by 78.28% to $242000.0 in 2024, then skyrocketed by 47.52% to $357000.0 in 2025.
  • Its Other financing activities was $357000.0 in Q3 2025, compared to $345000.0 in Q2 2025 and $1.9 million in Q1 2025.